These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36653758)

  • 1. Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report.
    Zeng X; Liu Q; Rathinasabapathy A; Zha L; Liu D; Tang Y; Sun J; Luo H; Yu Z
    BMC Pulm Med; 2023 Jan; 23(1):26. PubMed ID: 36653758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid disease progress in a PVOD patient carrying a novel EIF
    Zeng X; Chen F; Rathinasabapathy A; Li T; Adnan Ali Mohammed Mohammed A; Yu Z
    BMC Pulm Med; 2020 Jul; 20(1):186. PubMed ID: 32631303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.
    Zhang L; Wang Y; Zhang R
    Medicine (Baltimore); 2021 Oct; 100(41):e27334. PubMed ID: 34731104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
    Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
    Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of pulmonary veno-occlusive disease.
    Solinas S; Boucly A; Beurnier A; Kularatne M; Grynblat J; Eyries M; Dorfmüller P; Sitbon O; Humbert M; Montani D
    Expert Rev Respir Med; 2023; 17(8):635-649. PubMed ID: 37578057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature.
    Liang L; Ma G; Chen K; Liu Y; Wu X; Ying K; Zhang R
    Medicine (Baltimore); 2016 Sep; 95(39):e5030. PubMed ID: 27684876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary veno-occlusive disease: illustrative cases and literature review.
    Lechartier B; Boucly A; Solinas S; Gopalan D; Dorfmüller P; Radonic T; Sitbon O; Montani D
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38232988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension.
    Lai YJ; Chen PR; Huang YL; Hsu HH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):300-309. PubMed ID: 31202500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog.
    den Toom ML; Grinwis G; van Suylen RJ; Boroffka SA; de Jong P; van Steenbeek FG; Szatmári V
    Acta Vet Scand; 2018 Dec; 60(1):78. PubMed ID: 30518401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation.
    Liang L; Su H; Ma X; Zhang R
    Respir Res; 2018 Oct; 19(1):192. PubMed ID: 30285736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation].
    Treffel G; Guillaumot A; Gomez E; Eyries M; Petit I; Chabot JF; Chaouat A
    Rev Mal Respir; 2020 Dec; 37(10):823-828. PubMed ID: 33071063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.
    Montani D; Achouh L; Dorfmüller P; Le Pavec J; Sztrymf B; Tchérakian C; Rabiller A; Haque R; Sitbon O; Jaïs X; Dartevelle P; Maître S; Capron F; Musset D; Simonneau G; Humbert M
    Medicine (Baltimore); 2008 Jul; 87(4):220-233. PubMed ID: 18626305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
    Eyries M; Montani D; Girerd B; Perret C; Leroy A; Lonjou C; Chelghoum N; Coulet F; Bonnet D; Dorfmüller P; Fadel E; Sitbon O; Simonneau G; Tregouët DA; Humbert M; Soubrier F
    Nat Genet; 2014 Jan; 46(1):65-9. PubMed ID: 24292273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival.
    Navas Tejedor P; Palomino Doza J; Tenorio Castaño JA; Enguita Valls AB; Rodríguez Reguero JJ; Martínez Meñaca A; Hernández González I; Bueno Zamora H; Lapunzina Badía PD; Escribano Subías P
    Rev Esp Cardiol (Engl Ed); 2018 Feb; 71(2):86-94. PubMed ID: 28697925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
    Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
    J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren's syndrome following immunosuppressive therapy.
    Naniwa T; Takeda Y
    Mod Rheumatol; 2011 Dec; 21(6):637-40. PubMed ID: 21394665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two patients with mixed connective tissue disease complicated by pulmonary arterial hypertension showing contrasting responses to pulmonary vasodilators.
    Kusaka K; Nakano K; Iwata S; Kubo S; Nishida T; Tanaka Y
    Mod Rheumatol Case Rep; 2020 Jul; 4(2):253-261. PubMed ID: 33087021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
    Chaisson NF; Dodson MW; Elliott CG
    Clin Chest Med; 2016 Sep; 37(3):523-34. PubMed ID: 27514598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Characterization of
    Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
    Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and risk factors for primary Sjögren
    Chen Z; Tian J; Ouyang R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):339-346. PubMed ID: 37164917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.